Study population
heart failure, cardiogenic shock, fulminant myocarditis
ACUTE MYOCARDIAL INFARCTION, HEART FAILURE, CARDIOGENIC SHOCK
A retrospective study was conducted in a tertiary-level teaching hospital (Xuzhou Central Hospital). The study protocol was reviewed and approved by the Ethics Committee of our hospital and conforms to the Declaration of Helsinki.Between September 2015 and April 2022, twenty-two patients who underwent VA-ECMO support and LUS measurement and with cardiogenic shock were enrolled in the study. Eleven patients had acute myocardial infarction, 8 had fulminant myocarditis, and 3 had heart failure after cardiac surgery. The patients were divided into survivors (n = 16) and nonsurvivors (n = 6).In our centre, when the following criteria are met, VA-ECMO treatment is required for patients with refractory cardiogenic shock [